CST4 (cystatin S) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: CST4 (cystatin S) Homo sapiens
Analyze
Symbol: CST4
Name: cystatin S
RGD ID: 1345836
HGNC Page HGNC:2476
Description: Enables cysteine-type endopeptidase inhibitor activity. Involved in detection of chemical stimulus involved in sensory perception of bitter taste and negative regulation of proteolysis. Located in extracellular space.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: cystatin 4; cystatin-4; cystatin-S; cystatin-SA-III; MGC71923; salivary acidic protein 1
RGD Orthologs
Rat
Alliance Orthologs
More Info more info ...
Related Pseudogenes: CSTP1  
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382023,685,640 - 23,689,038 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2023,685,640 - 23,689,038 (-)EnsemblGRCh38hg38GRCh38
GRCh372023,666,277 - 23,669,675 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362023,614,277 - 23,617,662 (-)NCBINCBI36Build 36hg18NCBI36
Build 342023,614,276 - 23,617,662NCBI
Celera2023,739,545 - 23,742,930 (-)NCBICelera
Cytogenetic Map20p11.21NCBI
HuRef2023,626,229 - 23,629,613 (-)NCBIHuRef
CHM1_12023,666,297 - 23,669,682 (-)NCBICHM1_1
T2T-CHM13v2.02023,745,196 - 23,748,594 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
2. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:1334620   PMID:1471486   PMID:1741693   PMID:1747107   PMID:1778989   PMID:1801729   PMID:1898055   PMID:1898352   PMID:1939105   PMID:3202964   PMID:3488317   PMID:3496880  
PMID:6394600   PMID:6501254   PMID:7690606   PMID:7896273   PMID:8179826   PMID:8636877   PMID:8999869   PMID:9007972   PMID:10483070   PMID:11780052   PMID:11879580   PMID:12477932  
PMID:15489334   PMID:17207965   PMID:19199708   PMID:20383146   PMID:21873635   PMID:22664934   PMID:23376485   PMID:23580065   PMID:24248522   PMID:24261636   PMID:24952865   PMID:24981860  
PMID:25476789   PMID:26186194   PMID:27173435   PMID:27705803   PMID:28514442   PMID:30884312   PMID:31862882   PMID:32235678   PMID:32296183   PMID:32687490   PMID:32707033   PMID:33811900  
PMID:33961781   PMID:36369321   PMID:37122229   PMID:37314216  


Genomics

Comparative Map Data
CST4
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382023,685,640 - 23,689,038 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2023,685,640 - 23,689,038 (-)EnsemblGRCh38hg38GRCh38
GRCh372023,666,277 - 23,669,675 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362023,614,277 - 23,617,662 (-)NCBINCBI36Build 36hg18NCBI36
Build 342023,614,276 - 23,617,662NCBI
Celera2023,739,545 - 23,742,930 (-)NCBICelera
Cytogenetic Map20p11.21NCBI
HuRef2023,626,229 - 23,629,613 (-)NCBIHuRef
CHM1_12023,666,297 - 23,669,682 (-)NCBICHM1_1
T2T-CHM13v2.02023,745,196 - 23,748,594 (-)NCBIT2T-CHM13v2.0
Andpro
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr83157,171,739 - 157,178,262 (-)NCBIGRCr8
mRatBN7.23136,718,601 - 136,725,131 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl3136,718,602 - 136,724,966 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx3140,713,691 - 140,720,082 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.03149,297,399 - 149,303,796 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.03146,944,189 - 146,950,550 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.03143,893,005 - 143,899,609 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl3143,893,006 - 143,899,370 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.03150,274,643 - 150,281,008 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.43138,085,660 - 138,092,024 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.13137,991,232 - 137,997,597 (-)NCBI
Celera3135,466,151 - 135,472,515 (-)NCBICelera
Cytogenetic Map3q41NCBI

Variants

.
Variants in CST4
27 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 20p13-11.21(chr20:89939-25697564)x3 copy number gain See cases [RCV000051227] Chr20:89939..25697564 [GRCh38]
Chr20:70580..25678200 [GRCh37]
Chr20:18580..25626200 [NCBI36]
Chr20:20p13-11.21
pathogenic
GRCh38/hg38 20p11.22-q11.1(chr20:22061586-30285812)x3 copy number gain See cases [RCV000053000] Chr20:22061586..30285812 [GRCh38]
Chr20:22042224..29520488 [GRCh37]
Chr20:21990224..28134149 [NCBI36]
Chr20:20p11.22-q11.1
pathogenic
GRCh38/hg38 20p11.21(chr20:23455796-24880833)x3 copy number gain See cases [RCV000053001] Chr20:23455796..24880833 [GRCh38]
Chr20:23436433..24861469 [GRCh37]
Chr20:23384433..24809469 [NCBI36]
Chr20:20p11.21
pathogenic
GRCh38/hg38 20p12.2-q12(chr20:9811433-39316956)x3 copy number gain See cases [RCV000052999] Chr20:9811433..39316956 [GRCh38]
Chr20:9792081..37945599 [GRCh37]
Chr20:9740081..37379013 [NCBI36]
Chr20:20p12.2-q12
pathogenic
GRCh38/hg38 20p11.21(chr20:23455996-24050737)x3 copy number gain See cases [RCV000133802] Chr20:23455996..24050737 [GRCh38]
Chr20:23436633..24031374 [GRCh37]
Chr20:23384633..23979374 [NCBI36]
Chr20:20p11.21
uncertain significance
GRCh38/hg38 20p13-q11.1(chr20:80106-30227427)x3 copy number gain See cases [RCV000133996] Chr20:80106..30227427 [GRCh38]
Chr20:60747..29462103 [GRCh37]
Chr20:8747..28075764 [NCBI36]
Chr20:20p13-q11.1
pathogenic
GRCh38/hg38 20p13-q13.33(chr20:99557-64277321)x3 copy number gain See cases [RCV000135859] Chr20:99557..64277321 [GRCh38]
Chr20:80198..62908674 [GRCh37]
Chr20:28198..62379118 [NCBI36]
Chr20:20p13-q13.33
pathogenic
GRCh38/hg38 20p13-11.1(chr20:80927-26324843)x3 copy number gain See cases [RCV000142017] Chr20:80927..26324843 [GRCh38]
Chr20:61568..26305479 [GRCh37]
Chr20:9568..26253479 [NCBI36]
Chr20:20p13-11.1
pathogenic
GRCh37/hg19 20p11.21(chr20:23619740-23727830)x3 copy number gain Premature ovarian failure [RCV000225274] Chr20:23619740..23727830 [GRCh37]
Chr20:20p11.21
benign
GRCh37/hg19 20p13-11.1(chr20:80198-26075841)x3 copy number gain See cases [RCV000239954] Chr20:80198..26075841 [GRCh37]
Chr20:20p13-11.1
pathogenic
GRCh37/hg19 20p12.1-q11.21(chr20:17705775-31600738)x3 copy number gain See cases [RCV000240436] Chr20:17705775..31600738 [GRCh37]
Chr20:20p12.1-q11.21
pathogenic
GRCh37/hg19 20p13-q11.21(chr20:80198-26208081)x3 copy number gain not provided [RCV000487461] Chr20:80198..26208081 [GRCh37]
Chr20:20p13-q11.21
pathogenic
GRCh37/hg19 20p11.23-11.1(chr20:18500917-25847320)x1 copy number loss See cases [RCV000510621] Chr20:18500917..25847320 [GRCh37]
Chr20:20p11.23-11.1
pathogenic
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)x3 copy number gain See cases [RCV000510832] Chr20:61569..62915555 [GRCh37]
Chr20:20p13-q13.33
pathogenic
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555) copy number gain See cases [RCV000512450] Chr20:61569..62915555 [GRCh37]
Chr20:20p13-q13.33
pathogenic
GRCh37/hg19 20p11.22-11.21(chr20:21680345-24383453)x1 copy number loss See cases [RCV000663385] Chr20:21680345..24383453 [GRCh37]
Chr20:20p11.22-11.21
likely pathogenic
Single allele duplication not provided [RCV000677978] Chr20:17705775..31600738 [GRCh37]
Chr20:20p12.1-q11.21
pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62948788)x3 copy number gain not provided [RCV000741058] Chr20:63244..62948788 [GRCh37]
Chr20:20p13-q13.33
pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62961294)x3 copy number gain not provided [RCV000741059] Chr20:63244..62961294 [GRCh37]
Chr20:20p13-q13.33
pathogenic
GRCh37/hg19 20p11.21(chr20:23427399-23801509)x3 copy number gain not provided [RCV000741154] Chr20:23427399..23801509 [GRCh37]
Chr20:20p11.21
benign
GRCh37/hg19 20p13-q13.33(chr20:63244-62912463)x3 copy number gain not provided [RCV000741057] Chr20:63244..62912463 [GRCh37]
Chr20:20p13-q13.33
pathogenic
NM_001899.3(CST4):c.421G>T (p.Ala141Ser) single nucleotide variant not provided [RCV000881456] Chr20:23685899 [GRCh38]
Chr20:23666536 [GRCh37]
Chr20:20p11.21
benign
NM_001899.3(CST4):c.23T>A (p.Leu8Gln) single nucleotide variant not provided [RCV000948038] Chr20:23688947 [GRCh38]
Chr20:23669584 [GRCh37]
Chr20:20p11.21
benign
NM_001899.3(CST4):c.9G>A (p.Arg3=) single nucleotide variant not provided [RCV000948039] Chr20:23688961 [GRCh38]
Chr20:23669598 [GRCh37]
Chr20:20p11.21
benign
NM_001899.3(CST4):c.119A>G (p.Asn40Ser) single nucleotide variant not provided [RCV000948037] Chr20:23688851 [GRCh38]
Chr20:23669488 [GRCh37]
Chr20:20p11.21
benign
NM_001899.3(CST4):c.288G>A (p.Lys96=) single nucleotide variant not provided [RCV000955837] Chr20:23687142 [GRCh38]
Chr20:23667779 [GRCh37]
Chr20:20p11.21
benign
GRCh37/hg19 20p13-11.1(chr20:61568-26305479)x3 copy number gain not provided [RCV001007068] Chr20:61568..26305479 [GRCh37]
Chr20:20p13-11.1
pathogenic
GRCh37/hg19 20p11.23-q11.21(chr20:19750804-30479077)x3 copy number gain not provided [RCV001258738] Chr20:19750804..30479077 [GRCh37]
Chr20:20p11.23-q11.21
likely pathogenic
GRCh37/hg19 20p11.23-q11.22(chr20:18665879-33903216)x3 copy number gain not provided [RCV001829151] Chr20:18665879..33903216 [GRCh37]
Chr20:20p11.23-q11.22
likely pathogenic
GRCh37/hg19 20p11.21(chr20:23142478-24824349)x3 copy number gain not provided [RCV002474920] Chr20:23142478..24824349 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.175A>G (p.Thr59Ala) single nucleotide variant not specified [RCV004161642] Chr20:23688795 [GRCh38]
Chr20:23669432 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.17G>A (p.Cys6Tyr) single nucleotide variant not specified [RCV004163608] Chr20:23688953 [GRCh38]
Chr20:23669590 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.80A>G (p.Asn27Ser) single nucleotide variant not specified [RCV004169793] Chr20:23688890 [GRCh38]
Chr20:23669527 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.301T>G (p.Leu101Val) single nucleotide variant not specified [RCV004206847] Chr20:23687129 [GRCh38]
Chr20:23667766 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.332A>G (p.Glu111Gly) single nucleotide variant not specified [RCV004088409] Chr20:23687098 [GRCh38]
Chr20:23667735 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.56T>C (p.Leu19Pro) single nucleotide variant not specified [RCV004078174] Chr20:23688914 [GRCh38]
Chr20:23669551 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.335T>C (p.Leu112Pro) single nucleotide variant not specified [RCV004322688] Chr20:23687095 [GRCh38]
Chr20:23667732 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.280T>C (p.Cys94Arg) single nucleotide variant not specified [RCV004262307] Chr20:23687150 [GRCh38]
Chr20:23667787 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.44T>A (p.Leu15Gln) single nucleotide variant not specified [RCV004348417] Chr20:23688926 [GRCh38]
Chr20:23669563 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.271C>T (p.Arg91Cys) single nucleotide variant not specified [RCV004336850] Chr20:23687159 [GRCh38]
Chr20:23667796 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.54T>C (p.Ala18=) single nucleotide variant not provided [RCV003440362] Chr20:23688916 [GRCh38]
Chr20:23669553 [GRCh37]
Chr20:20p11.21
likely benign
NM_001899.3(CST4):c.93A>G (p.Pro31=) single nucleotide variant not provided [RCV003440361] Chr20:23688877 [GRCh38]
Chr20:23669514 [GRCh37]
Chr20:20p11.21
likely benign
NM_001899.3(CST4):c.45G>A (p.Leu15=) single nucleotide variant not provided [RCV003440363] Chr20:23688925 [GRCh38]
Chr20:23669562 [GRCh37]
Chr20:20p11.21
likely benign
NM_001899.3(CST4):c.347A>T (p.Gln116Leu) single nucleotide variant not specified [RCV004372724] Chr20:23685973 [GRCh38]
Chr20:23666610 [GRCh37]
Chr20:20p11.21
uncertain significance
NC_000020.10:g.16400000_24400000del deletion Hyperinsulinemic hypoglycemia, familial, 1 [RCV003992661] Chr20:16400000..24400000 [GRCh37]
Chr20:20p12.1-11.21
pathogenic
GRCh37/hg19 20p13-11.21(chr20:68351-23860313)x3 copy number gain not provided [RCV003885495] Chr20:68351..23860313 [GRCh37]
Chr20:20p13-11.21
pathogenic
NM_001899.3(CST4):c.260T>A (p.Val87Glu) single nucleotide variant not specified [RCV004372722] Chr20:23687170 [GRCh38]
Chr20:23667807 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.236G>C (p.Gly79Ala) single nucleotide variant not specified [RCV004372721] Chr20:23687194 [GRCh38]
Chr20:23667831 [GRCh37]
Chr20:20p11.21
likely benign
NM_001899.3(CST4):c.272G>A (p.Arg91His) single nucleotide variant not specified [RCV004372723] Chr20:23687158 [GRCh38]
Chr20:23667795 [GRCh37]
Chr20:20p11.21
uncertain significance
NC_000020.10:g.20158646_24080787del deletion Hyperinsulinemic hypoglycemia, familial, 1 [RCV003992658] Chr20:20158646..24080787 [GRCh37]
Chr20:20p11.23-11.21
pathogenic
NM_001899.3(CST4):c.142C>G (p.Leu48Val) single nucleotide variant not specified [RCV004615744] Chr20:23688828 [GRCh38]
Chr20:23669465 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.331G>A (p.Glu111Lys) single nucleotide variant not specified [RCV004615745] Chr20:23687099 [GRCh38]
Chr20:23667736 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.50G>A (p.Gly17Glu) single nucleotide variant not specified [RCV004908390] Chr20:23688920 [GRCh38]
Chr20:23669557 [GRCh37]
Chr20:20p11.21
uncertain significance
NM_001899.3(CST4):c.8G>A (p.Arg3Gln) single nucleotide variant not specified [RCV004908391] Chr20:23688962 [GRCh38]
Chr20:23669599 [GRCh37]
Chr20:20p11.21
likely benign
NM_001899.3(CST4):c.255C>G (p.Phe85Leu) single nucleotide variant not specified [RCV004908392] Chr20:23687175 [GRCh38]
Chr20:23667812 [GRCh37]
Chr20:20p11.21
likely benign
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:315
Count of miRNA genes:281
Interacting mature miRNAs:293
Transcripts:ENST00000217423
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
G42975  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372023,728,253 - 23,728,455UniSTSGRCh37
GRCh372023,666,331 - 23,666,533UniSTSGRCh37
Build 362023,614,331 - 23,614,533RGDNCBI36
Celera2023,739,599 - 23,739,801RGD
Celera2023,801,529 - 23,801,731UniSTS
Cytogenetic Map20p11.21UniSTS
HuRef2023,626,283 - 23,626,485UniSTS
HuRef2023,687,467 - 23,687,669UniSTS
CST4_7775  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372023,666,091 - 23,666,553UniSTSGRCh37
Build 362023,614,091 - 23,614,553RGDNCBI36
Celera2023,739,359 - 23,739,821RGD
HuRef2023,626,043 - 23,626,505UniSTS
RH71431  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372023,804,695 - 23,804,826UniSTSGRCh37
GRCh372023,666,569 - 23,666,700UniSTSGRCh37
Build 362023,614,569 - 23,614,700RGDNCBI36
Celera2023,739,837 - 23,739,968RGD
Celera2023,878,077 - 23,878,208UniSTS
Cytogenetic Map20p11.21UniSTS
HuRef2023,761,721 - 23,761,852UniSTS
GeneMap99-GB4 RH Map20123.03UniSTS
NCBI RH Map20188.2UniSTS


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
entire extraembryonic component
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
pharyngeal arch
renal system
reproductive system
respiratory system
sensory system
67 247 276 145 577 830 1119 2 98 147 58 281 898 705 7 427 1 338 781 843 44

Sequence


Ensembl Acc Id: ENST00000217423   ⟹   ENSP00000217423
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2023,685,640 - 23,689,038 (-)Ensembl
RefSeq Acc Id: NM_001899   ⟹   NP_001890
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382023,685,640 - 23,689,038 (-)NCBI
GRCh372023,666,277 - 23,669,662 (-)ENTREZGENE
Build 362023,614,277 - 23,617,662 (-)NCBI Archive
HuRef2023,626,229 - 23,629,613 (-)ENTREZGENE
CHM1_12023,666,297 - 23,669,682 (-)NCBI
T2T-CHM13v2.02023,745,196 - 23,748,594 (-)NCBI
Sequence:
RefSeq Acc Id: NP_001890   ⟸   NM_001899
- Peptide Label: precursor
- UniProtKB: Q9UBI5 (UniProtKB/Swiss-Prot),   Q9UCS9 (UniProtKB/Swiss-Prot),   P01036 (UniProtKB/Swiss-Prot)
- Sequence:
Ensembl Acc Id: ENSP00000217423   ⟸   ENST00000217423

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P01036-F1-model_v2 AlphaFold P01036 1-141 view protein structure

Promoters
RGD ID:13206545
Promoter ID:EPDNEW_H26853
Type:multiple initiation site
Name:CST4_1
Description:cystatin S
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh382023,689,038 - 23,689,098EPDNEW
RGD ID:6851242
Promoter ID:EP73409
Type:single initiation site
Name:HS_CST4
Description:Cystatin S.
SO ACC ID:SO:0000170
Source:EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:NEDO full length human cDNA sequencing project.; Oligo-capping
Position:No map positions available.

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:2476 AgrOrtholog
COSMIC CST4 COSMIC
Ensembl Genes ENSG00000101441 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000217423 ENTREZGENE
  ENST00000217423.4 UniProtKB/Swiss-Prot
Gene3D-CATH 3.10.450.10 UniProtKB/Swiss-Prot
GTEx ENSG00000101441 GTEx
HGNC ID HGNC:2476 ENTREZGENE
Human Proteome Map CST4 Human Proteome Map
InterPro Cystatin_dom UniProtKB/Swiss-Prot
  Cystatin_sf UniProtKB/Swiss-Prot
  Prot_inh_cystat_CS UniProtKB/Swiss-Prot
KEGG Report hsa:1472 UniProtKB/Swiss-Prot
NCBI Gene 1472 ENTREZGENE
OMIM 123857 OMIM
PANTHER CYSTATIN UniProtKB/Swiss-Prot
  CYSTATIN-S-RELATED UniProtKB/Swiss-Prot
Pfam Cystatin UniProtKB/Swiss-Prot
PharmGKB PA26977 PharmGKB
PROSITE CYSTATIN UniProtKB/Swiss-Prot
SMART SM00043 UniProtKB/Swiss-Prot
Superfamily-SCOP SSF54403 UniProtKB/Swiss-Prot
UniProt CYTS_HUMAN UniProtKB/Swiss-Prot, ENTREZGENE
  Q9UBI5 ENTREZGENE
  Q9UCS9 ENTREZGENE
UniProt Secondary Q9UBI5 UniProtKB/Swiss-Prot
  Q9UCS9 UniProtKB/Swiss-Prot